GC

Girish Chander Pandey

Active Director Director DIN 11538626
DIN 11538626 First appointment Feb 2026 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Girish Chander Pandey

Data last updated:

Girish Chander Pandey is a Director at Glarix Pharmaceuticals Private Limited (since 2026). The company operates in Pharma.

DIN 11538626
Primary Designation Director
Industry Pharma
First Appointment 11 Feb 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director11 Feb 20262026Active

Board colleagues of Girish Chander Pandey

NameDINCompanyDesignation
Arti Mishra11538625Glarix Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Glarix Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Girish Chander Pandey

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Girish Chander Pandey

Girish Chander Pandey currently holds 1 directorship: Glarix Pharmaceuticals Private Limited (Director, since 11 Feb 2026).

Girish Chander Pandey was first appointed on 11 Feb 2026 as Director at Glarix Pharmaceuticals Private Limited.

The current boards of Girish Chander Pandey's companies include Arti Mishra (Glarix Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available